China Medical System Holdings Limited (CHSYF)

Market Cap	4.70B +109.0%
Revenue (ttm)	1.10B +12.1%
Net Income	230.40M +18.7%
EPS	0.10 +20.1%
Shares Out	n/a
PE Ratio	20.38
Forward PE	17.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,191
Open	1.350
Previous Close	1.350
Day's Range	1.350 - 1.350
52-Week Range	1.350 - 1.636
Beta	1.01
RSI	47.17
Earnings Date	Mar 16, 2026

About CHSYF

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 6,095
• Stock Exchange: OTCMKTS
• Ticker Symbol: CHSYF

Financial Performance

In 2024, CHSYF's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY